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The effects of thyroid hormones on uroflowmetry parameters in asymptomatic women
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Aim: To investigate whether there is any association between uroflowmetry parameters and blood levels of thyroid hormones in
asymptomatic women.
Materials and methods: Included in the study were 110 consecutive female patients with no urinary complaints who had thyroid
function tests performed in an endocrinology clinic. Uroflowmetric measurements were performed for each patient in a sitting position.
The patients were divided into 3 groups, hypo-, hyper-, and euthyroidism, and were investigated for statistical difference among them
regarding maximum flow rate (Qmax), average flow rate (Qave), voided volume (VV), and voiding time (VT).
Results: The mean Qmax and Qave values of hypo-, eu-, and hyperthyroid groups were 25.3 ± 9.1 and 14.9 ± 5.8, 28.6 ± 9.6 and 16.2 ±
6.4, and 21.5 ± 8.7, and 13.2 ± 5.6, respectively. In the evaluation of all groups, a statistically significant difference was found regarding
Qmax (P = 0.004) and Qave (P = 0.024). When the groups were evaluated between each other, Qmax (p = 0.003) and Qave (P = 0.027)
were significantly different between hyper- and euthyroid groups, with no statistically significant differences in other groups regarding
the uroflowmetry parameters (P > 0.05).
Conclusion: It has been found that Qmax and Qave were significantly lower in the hyperthyroid group as compared with the euthyroid
group. According to these findings, it may be thought that hyperthyroidism negatively affects uroflowmetry parameters. To reach a
definitive judgment, more investigations supported by urodynamic studies are necessary.
Key words: uroflowmetry, thyroid hormone, urination

1. Introduction
Thyroid hormones play an important role in the metabolic
action of almost all organs, such as the cardiovascular,
respiratory, and gastrointestinal systems (1–3). Thyroid
hormone levels must be in a steady state for homeostasis.
Thyroid disorders are very common and one of the most
frequent problems in endocrinology practice, following
diabetes mellitus. In the United States, hyperthyroidism
and hypothyroidism are present in 1.3% and 4.6% of the
population, respectively (4). All types of thyroid disorders
in women are much more common than those in men
(5,6).
Normal functioning of the urinary bladder is dependent
upon regular function of the detrusor muscle during the
storage and voiding phases. The relaxation and contraction
functions of the detrusor muscle are mediated by several
neural circuits, including sympathetic, parasympathetic,
and somatic nerves (7). Thyroid hormone levels in blood
circulation are highly effective on the autonomic nervous
system (8). In hyperthyroid patients, sympathetic activity
* Correspondence: ersincimentepe@yahoo.com

increases and parasympathetic activity decreases, while the
opposite situation might be detected in hypothyroidism.
These alterations in the autonomic nervous system,
depending on the thyroid hormone levels, may interact
with lower urinary tract (LUT) function.
The aims of this study were to evaluate the voiding
function using noninvasive uroflowmetric measurements
and to investigate whether there was any relationship
between LUT functions and thyroid hormone levels in
female patients without any urinary complaints.
2. Materials and methods
This study included 110 female patients attending
endocrine clinics and having their thyroid hormone panel
detected at our institution between September 2009 and
August 2010. Male subjects were not included in the study
in order to avoid the conflicting effect of the prostate on
micturition dynamics that can be seen in middle-aged
men. None of the patients had any urinary complaints
during their attendance. The participants were divided
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into 3 groups, including hypo-, eu-, and hyperthyroidism,
according to their thyroid status. The thyroid status of
the patients was determined by an endocrine specialist
based on both clinical presentations and serum levels
of thyroid hormones. The serum levels of thyroidstimulating hormone (TSH), free triiodothyronine
(fT3), and free thyroxine (fT4) were measured using the
chemiluminescence immunoassay method. The normal
range of TSH, fT3, and fT4 were 0.1–4.5 µIU/mL, 1.5–4.4
pg/mL, and 10.2–24.4 pmol/L, respectively.
All participants were screened by means of physical
examinations, urinalysis, and abdominopelvic ultrasound
in order to determine the presence of any urinary disorder.
Subjects were excluded from the study if they had previous
pelvic surgery, concurrent neurological disease, or use of
any medication known to interfere with the autonomic
nervous system and/or lower urinary tract function
such as anticholinergics, diuretics, sympathomimetics,
sympatholytics, antidepressants, and antipsychotics.
Uroflowmetric measurements were performed in
a private room that was locked from the inside and out
of the hearing range of other staff members. All subjects
performed uroflowmetric measurements when they felt
the need to urinate during their daily activities. Subjects
did not change their daily drinking habits and none
of them received either a diuretic or a large fluid bolus.
Measurements were done in a sitting position. All subjects
were instructed to void without increasing their abdominal
pressure. Urinary flow rates were measured using a weight
transducer uroflowmetry device (Dyno Urodynamic
System, Aymed Medical Technologies, Turkey). Voided
volumes of <150 mL and >500 mL were disregarded for
further analysis and the measurements were repeated.
Mean maximum flow rate (Qmax), average flow rate
(Qave), voided volume (VV), and voiding time (VT) were
recorded for each group.
Statistical analysis was performed using SPSS 16.0
(SPSS Inc., Chicago, IL, USA). All results are presented as
mean ± standard deviation (SD). One-way ANOVA was
used to evaluate the intergroup differences regarding the

uroflowmetry parameters. Differences were considered to
be statistically significant at P < 0.05.
The local ethics committee approved the study protocol.
Informed consents of all participants were obtained before
the study began. Subjects did not receive any financial
compensation for the time spent performing the study.
3. Results
The mean age, body mass index (BMI), and serum levels
of thyroid hormones are shown in Table 1. There were no
statistically significant differences regarding the mean age
and mean BMI among all groups. In contrast, statistically
significant differences were found in thyroid hormone
levels among the groups, as expected.
The uroflowmetric measurements are also shown in
Table 2. Statistically significant differences were found
regarding Qmax and Qave when the uroflowmetric
parameters of all 3 groups were compared (P = 0.004 and
0.024, respectively). When the groups were compared
in pairs, there were statistically significant differences
regarding the mean Qmax and Qave between the hyperand euthyroidism groups, while there were no significant
differences between the hyper- and hypothyroidism or the
hypo- and euthyroidism groups (P > 0.05). Similarly, no
statistically significant differences were found regarding
the VV and VT parameters among all groups (P > 0.05).
4. Discussion
Our preliminary study was intended to investigate whether
any association between uroflowmetric parameters and
thyroid status revealed a significant decrease in urinary
flow rates in patients with hyperthyroidism compared to
patients with euthyroidism.
The most commonly used technique for the evaluation
of LUT functions is uroflowmetry, which can be
performed easily and in a simple manner. Uroflowmetric
measurements could be done in a sitting or crouching
position in women. It has been demonstrated that there
is no difference between these positions regarding the
uroflowmetric parameters (9). Nevertheless, we instructed

Table 1. Age, BMI, and thyroid hormone levels for each group (mean ± SD).
Hypothyroidism
(n = 32)

Euthyroidism
(n = 51)

Hyperthyroidism
(n = 27)

P

Age

43.5 ± 11.8

39.9 ± 11.3

44.6 ± 10.6

0.179

BMI

30.8 ± 6.7

27.8 ± 5.9

28.9 ± 6.1

0.060

TSH

11.8 ± 9.1

3.8 ± 4.9

0.31 ± 3.3

0.000

fT3

2.5 ± 0.7

3.0 ± 0.6

4.4 ± 4.6

0.002

fT4

12.1 ± 4.6

15.3 ± 3.4

19.0 ± 5.8

0.000

BMI: body mass index, TSH: thyroid-stimulating hormone, fT3: free triiodothyronine, fT4: free thyroxine.
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Table 2. Uroflowmetric parameters for each group (mean ± SD).
Qmax
(mL/s)

Qave
(mL/s)

VV
(mL)

VT
(s)

25.3 ± 9.1

14.9 ± 5.8

280.4 ± 130.4

21.6 ± 12.9

Euthyroidism

28.6 ± 9.6

16.2 ± 6.4

315.1 ± 119.6

24.0 ± 12.7

Hyperthyroidism

21.5 ± 8.7

13.2 ± 5.6

389.3 ± 124.3

27.1 ± 13.9

0.265
1.000
0.027

0.934
1.000
0.602

1.000
0.558
0.912

Hypothyroidism

P

Hypo- vs, euthyroidism
0.447
Hypo- vs. hyperthyroidism 0.203
Eu- vs. hyperthyroidism
0.003

Qmax: maximum flow rate, Qave: average flow rate, VV: voided volume, VT: voiding time.

the subjects to void in a sitting position to provide
standardization.
Alteration in thyroid hormone levels is characterized
by a variety of clinical features that closely mimic
those of catecholamine levels in the circulation (i.e.
tachycardia, sweating, tremor, diarrhea) (10). For example,
hyperthyroidism causes an increased sympathetic activity
by enhancing cellular response to adrenergic activity. There
are 3 types of nervous systems innervating the smooth
muscles of bladder and proximal urethra: sympathetic,
parasympathetic, and somatic (7). In a normal voiding
process, detrusor muscles contract by parasympathetic
stimulation, bladder neck and proximal urethral smooth
muscles relax by alpha-adrenergic activity, and the striated
urethral sphincter relaxes by somatic innervations.
Therefore, LUT functions might be affected by the changes
in the autonomic nervous system (ANS). For example,
hyperthyroidism that is characterized by increased
adrenergic activity might cause an inhibition in detrusor
muscle action. Indeed, in an animal study, Hess et al.
found an increased beta-adrenergic receptor density of the
urinary bladder strip in hyperthyroid rats (11).
The effects of thyroid hormone alterations on LUT
function have not been studied extensively. In the current
literature, there is very scant information regarding the
relationship between thyroid hormones and voiding
function. In their clinical trial investigating LUT
symptoms and urinary flow rates in female patients with
hyperthyroidism, Ho et al. concluded that hyperthyroid
women had worse LUT symptoms and lower peak flow
rates (12). The results of this study regarding the urinary
flow rates are in accordance with our results. Similarly,

Andersen et al. investigated the voiding patterns in patients
with thyroid disease and demonstrated that hyperthyroid
patients had significantly increased voiding frequency and
nocturia (13), whereas we did not reach any comment
about LUT symptoms, since only subjects without any
urinary complaints were included in our study.
Studies investigating the effect of hypothyroidism on
voiding function are even fewer. There are a few cases of
reported urinary retention due to hypothyroidism in the
literature (14,15). However, we did not find any differences
in the uroflowmetric parameters between hypothyroidism
and hyper- or euthyroidism.
Our study is limited by the lack of urodynamic
assessment, including detrusor pressure and pressureflow study. As is known, decreased urinary flow rates
might be dependent on both infravesical obstruction and/
or impaired bladder contractility. However, urodynamic
studies are less often used in clinical practice due to
their invasive manner, despite the fact that more precise
information to explore the exact mechanism of LUT
functions could be provided by these diagnostic methods.
In this study, the effects of thyroid status on the
lower urinary tract were evaluated with noninvasive
uroflowmetric measurements. Urinary flow rates were
significantly lower in patients with hyperthyroidism than
those of euthyroidism. The most reasonable explanation of
this effect is ANS alterations such as increased adrenergic
activity at the level of detrusor muscle or even more
central levels of LUT innervations. The exact mechanism
of LUT dysfunction in thyroid disorders require further
investigations, including urodynamic studies, in larger
patient groups.
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